Computational simulation of the predicted dosimetric impact of adjuvant yttrium-90 PET/CT-guided percutaneous ablation following radioembolization

EJNMMI Research

Table 1 Patient demographic and ⁹⁰Y radioembolization treatment data

Patient	Disease	Tumor volume (cm³)	Treatment device	Infused ⁹⁰Y activity (GBq)
1	HCC	124.1	Resin	1.30
2	HCC	270.4	Resin	1.39
2	HCC	241.3	Resin	1.39
3	HCC	276.4	Resin	1.67
4	Cholangio	100.7	Resin	0.62
5	HCC	374.6	Resin	1.24
6	Cholangio	44.4	Resin	0.92
7	Endometrial	203.2	Resin	1.14
8	HCC	220.9	Resin	1.01
9	HCC	213.4	Resin	1.83
10	HCC	42.5	Resin	1.54
11	Breast	60.2	Resin	1.17
12	HCC	104.7	Glass	2.51
13	HCC	323.4	Glass	4.13
14	HCC	258.2	Glass	3.23